Studies of serum-resistant Salmonella minnesota have suggested that resistance in this bacterium is related to failure of the complement membrane attack complex (MAC) to insert into hydrophobic domains of the outer membrane (17, 18) . We undertook the following studies to assess the interaction of the complement system with resistant and sensitive _IV.. gonorrhoeae to characterize the relationship of the complement system to serum resistance.
Materials and Methods
Serum. Pooled NHS was prepared by centrifugation (2,000 g at 4°C) of freshly clotted blood (30-60 min at room temperature) obtained from three or more normal volunteers who had no history of gonococcal infection. This pooled NHS was used in all experiments except as indicated otherwise. Heat-inactivated NHS (ANHS) was prepared by heating NHS at 56°C for 30 min.
Bacteria. Serum-resistant strains (Willis and Davis) were isolated from blood or joint fluids of patients with DGI. One serum-sensitive strain (N24) was obtained from the San Diego Public Health Laboratories and another (F62) from Dr. Jerry Brown (Center for Disease Control, Atlanta, GA). Bacteria were maintained at -70°C in citrated rabbit blood until use. When needed, bacteria were grown on GC agar plates supplemented with 1% IsoVitaleX (BBL Microbiology Systems, Becton, Dickinson & Co., Cockeysville, MD) at 37°C in 5% COz and subcultured daily by selecting multiple colonies of typical T2 colonial morphology (19) . For cloning experiments, single colonies were selected, plated, and grown at 37°C in 5% CO2.
Bactericidal Assays. Gonococci grown 18-24 h were examined to ensure that >99% were T2 colony type, suspended in Dulbecco's minimal essential media (MEM) (Gibco Laboratories, Grand Island Biological Co., Grand Island, NY) by vigorous pipetting for uniform dispersion, and centrifuged (64 g) for 30 s to sediment agar and large clumps of bacteria. The suspension was adjusted by addition of MEM to an absorbance 610 nm (A610) corresponding to the desired concentration of bacteria. The correlation between A810 and bacterial concentration had been determined previously by plate counts. Equal amounts of Bacterial suspension and NHS or ANHS were mixed and incubated at 37°C in 5% CO2 for 1 h. After incubation, bacterial viability was determined as previously described (20) . The bactericidal capacity of NHS was expressed either as the difference between the number of colony-forming units (CFU) surviving in ANHS and in NHS or, in the case of log10 killing, as the difference between the log~0 of the number of CFU in ANHS and in NHS.
Complement Depletion Assays. Suspensions of bacteria varying from 107/ml to 109/ml were prepared in MEM, mixed with equal amounts of NHS, and incubated at 37°C in 5% CO2 for 1 h. For determination of the amount of complement in serum not exposed to bacteria, equal amounts of NHS and MEM were mixed and incubated. After incubation, an aliquot from each sample was removed for a bactericidal assay, and the remaining sample was centrifuged (15,000 g) for 10 min in a microfuge to pellet the bacteria. The supernatant was removed and used for complement determinations or frozen at -70°C if determinations were not done immediately.
The total hemolytic activity (CHs0), C4 hemolytic activity, and C2 hemolytic activity were determined by standard procedures (21) . C7 hemolytic activity was determined as follows. C7-depleted serum (C7d) was prepared by affinity chromatography (22) . A 1:20 dilution of the test sample was prepared, and 2-20s/~1 aliquots were added to mixtures of 0.1 ml antibodysensitized sheep erythrocytes (5 X 10/ml), 0.3 ml veronal-buffered saline with gelatin (GVB), and 0.02 ml C7d serum on ice and then incubated at 37°C for 30 min. After incubation, 1.0 ml cold GVB was added, each mixture centrifuged (500 g) for 3 min, and the A412 of the supernatant determined. The C7 hemolytic activity expressed as z/ml was calculated.
Cls Activation Assay. Activation of C ls was determined as previously described (23) . In brief, purified Cls, kindly provided by Dr. Robert Ziccardi of Scripps Clinic and Research Foundation, was labeled with 125I (New England Nuclear, Boston, MA) by the solid-phase lactoperoxidase method to a specific activity of 0.5 #Ci//~g. 12SI-Cls at 5% of the concentration of Cls in normal serum was added to NHS and equilibrated for 60 min at 37°C. Bacterial pellets were prepared by adding suspensions containing 108 or 109 bacteria to microfuge tubes, centrifuging (10,000 g) for 5 min and removing the supernatants. Next, 0.025 ml of NHS containing 125I-C ls was added to the bacterial pellets, vortexed vigorously to suspend the bacteria, and incubated at 37°C for 30 min. To assess spontaneous activation of Cls, 0.025 ml NHS containing 125I-Cls was added to 0.025 ml MEM in the absence of bacteria. Cls activation was also assessed by adding 0.25 ml NHS containing 125I-Cls to 100 #g human aggregated IgG (HAGG). (The HAGG was prepared by heating the IgG [10 mg/ml] at 63°C for 20 min and centrifuging [10,000 g] for 3 min to remove large complexes.) After incubation at 37°C for 30 min, EDTA (10 mM final concentration) was added to the mixtures, vortexed, allowed to stand for 5 min, and then the bacteria were pelleted. The ~2~I-Cls in the supernatant was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in tube gels (3% stacking gel, 7% separating gel) under reducing conditions according to Laemmli (24) . The gels were cut into 1.5-ram segments, and each slice was counted in a gamma scintillation spectrometer. Cls activation was determined as the fraction of total counts (in percent) migrating as activated 125I-Cls. Specific Cls activation was determined by subtracting the percent Cls activated in NHS incubated with MEM from the percent Cls activation produced by HAGG or bacteria samples.
C5 Activation and Binding Assay. C5 was purified as described (25) except as a final step, affinity chromatography on concanavalin A-Sepharose 4B was used, and then labeled with 1~5I incubated at 37°C in 5% COs for 1 h. Samples containing rabbit erythrocytes (ER) (1 × 10 s) and zymosan (250/~g) were also prepared to assess C5 activation and binding in this assay. One set of the duplicate samples was then centrifuged (10,000 g) for 5 rain, and aliquots of the supernatants and pellets were analyzed for le5I-C5 activation on a SDS-PAGE slab gel (3°7o stacking gel, 7% separating gel) under reducing conditions according to Laemmli (24) . The gel was dried and an autoradiograph was prepared to assess conversion of C5 to C5b. The second set of samples was analyzed for 12SI-C5 binding to the bacteria by vortexing, layering the samples on top of 0.3 ml of 10% (wt/vol) sucrose in veronal-buffered saline with Ca ++ and Mg ++ (VB ++) containing 0.1 mg ovalbumin (Calbiochem-Behring Corp., La Jolla, CA) per ml in 0.4 ml microfuge tubes, and centrifuging (10,000 g) for 3 rain. The supernatants and pellets were separated by removing the bottoms of the tubes with a razor blade and counting in a gamma scintillation spectrometer. Molecules of C5 bound per cell were determined as follows. Molecules of C5 in the NHS containing a25I-C5 were calculated based on normal serum concentration of C5 (70/zg/ml). The functional activity of a25I-C5 used was estimated to be 33% based on maximum incorporation of 125I-C5 into SC5b-9 in NHS upon activation by zymosan (10 mg/ml) (27) . The amount of x25I-C5 bound was corrected for functional activity of ~25I-C5 to calculate total C5 binding. Finally, the total C5 bound was divided by the number of bacteria (109) in the assay.
Specific binding of x25I-C5 to the bacteria was determined according to the following formula:
t~I-C5 and 1aII-C9 Binding Assay. Purified C5 and C9 (28) were prepared and differentially labeled with 125I and aalI (ICN Nutritional Biochemicals, Cleveland, OH) respectively, by the iodogen method. The specific activity of la1I-C9 was 0.4/~Ci//~. Freshly centrifuged 131I-C9 (10,000 g for 5 min) was added to NHS and ANHS to give 2 X 10 cpm/ml serum. The specific activity of a25I-C5 and amount added to NHS and ANHS were as described for the C5 activation and binding assay. To bacterial pellets containing l0 s bacteria prepared in microfuge tubes as described above, increasing amounts of NHS containing a25I-C5 and laxI-C9 were added. The mixtures were vortexed and incubated at 37°C in 5% CO~ for 1 h. ANHS (0.5 ml) containing ~25I-C5 and laaI-C9 was incubated with bacterial pellets to determine nonspecific binding. After incubation, MEM was added as necessary to a final volume of 0.5 ml. An aliquot (0.1 ml) was removed from each tube and layered on 0.3 ml of 10% (wt/vol) sucrose in VB ++ containing 1.0 mg ovalbumin/ml in a 0.4 ml microfllge tube. The tubes were then centrifuged, after which supernatants and pellets were separated and counted for both 125I-C5 and 131I-C9. The 125I counts were corrected for crossover from 131I. The molecules of C5 and C9 bound per cell were calculated as described above. Calculations were based on 33% 131I-C9 functional activity. The C9/C5 ratio was calculated from the molecules per cell data.
Assay of SC5b-9 Formation. Aliquots of the supernatants obtained from the C5 activation and binding assay were layered on top of a 4.5-ml 10%-40% sucrose gradient in VB ++ with a 0.5 ml 66% sucrose cushion. The samples were centrifuged in a Beckman ultracentrifuge (L5-65; Beckman Instruments, Inc., Fullerton, CA) with a SW50.1 rotor at 36,000 rpm, 4°C for 16 h. The samples were then fractionated and counted in a gamma scintillation spectrometer for 125I-C5. The location of radiolabeled SC5b-9 within the gradient was determined from zymosantreated samples, and the percent of 125I-C5 incorporated into SC5b-9 was calculated.
Electron Microscopy. Bacteria were incubated with MEM, NHS, or ANHS as described for the bactericidal assays. After incubation, they were centrifuged (10,000 g) for 5 rain, washed twice with 0.2 ml of 0.5 M phosphate buffer (pH 8.0), and resuspended in 0.2 ml VB ++. To each sample, 20/~g of trypsin and 20/~g of chymotrypsin (Worthington Biochemical Corp., Freehold, N J) were added before overnight incubation at room temperature. The samples were then washed twice in 0.2 ml VB ++ and resuspended in 0.05 ml VB ++, after which 5 ~1 was placed on parlodion and carbon-coated 400-mesh copper grids, stained with 1-2% uranyl formate, and examined in a Hitachi 12A electron microscope operated at 75 kv accelerating voltage and a direct magnification of 40,000.
Results

Effect of NHS on Serum-resistant and Serum-sensitive N. gonorrhoeae.
To determine the bactericidal capacity of NHS against resistant and sensitive N. gonorrhoeae, we determined the bacteria surviving as CFU when increasing numbers of bacteria were added to a constant volume of NHS. Fig. 1 shows that essentially all bacteria of the serum-sensitive strain N24 were killed when 107 CFU were added to 1 ml of NHS. As the concentration of N24 incubated with NHS was increased, more bacteria (CFU) were killed, but a smaller percentage of the total number was killed (decreasing log10 killed). In contrast, there was no significant killing (<0.1 log) of the serum-resistant strain Willis at bacterial concentrations of 107-108/ml.
Because subsequent experiments (see below) showed that complement was activated , and a serum-sensitive strain, N24 (©) as increasing numbers of CFU were incubated with 1 ml of NHS.
by serum-resistant N. gonorrhoeae, it became important to determine if any resistant bacteria could be killed by NHS. Because our standard bactericidal assay does not detect killing of small numbers of bacteria when high bacterial concentrations (I0S/ ml) are used, additional experiments in which 104 bacteria/ml had been added to NHS were performed. Results of five identical experiments showed that the decrease in CFU incubated in NHS compared with ANHS was 29% -+ 17% for the resistant Willis strain and 19% + 21% for the resistant Davis strain. To exclude the possibility that a subpopulation of relatively serum-sensitive clones existed within the population of the serum-resistant strain, 10 separate clones of Willis were also tested in bactericidal assays at a concentration of I0 s bacteria/ml of NHS. None of the clones exhibited more than a 0.2 log decrease in the number of CFU in NHS compared with ANHS.
Depletion of Complement Components. In a series of experiments, the CH50, C4, C2, and C 7 activities were determined in NHS after incubation with resistant and sensitive N. gonorrhoeae (Table I ). The serum-resistant strain Willis depleted 25% of the CH~0 activity and 33% of the C2 activity in NHS. The two serum-sensitive strains F62 and N24 depleted ~33% of the CHso activity and 50% of the C2 activity in NHS. Neither C4 nor C7 activity was depleted in detectable amounts by either resistant or sensitive T o e v a l u a t e t h e dose-response r e l a t i o n s h i p s b e t w e e n t h e n u m b e r o f b a c t e r i a incub a t e d in N H S a n d c o n s u m p t i o n of c o m p l e m e n t , different a m o u n t s (107-109) o f b a c t e r i a were a d d e d to 1 m l of N H S . As seen in T a b l e II, b o t h s e r u m -r e s i s t a n t s t r a i n s (Willis a n d Davis) a n d -sensitive s t r a i n s (F62 a n d N24) 
Activation of C1.
T o e v a l u a t e a c t i v a t i o n o f t h e classical p a t h w a y , 10 s b a c t e r i a were i n c u b a t e d w i t h 0.025 m l of N H S c o n t a i n i n g a25I-C 1 s. N o C 1 s a c t i v a t i o n was d e t e c t a b l e w i t h e i t h e r resistant or sensitive s t r a i n s ( T a b l e III). H o w e v e r , w h e n 109 b a c t e r i a were a d d e d to 0.025 m l of N H S c o n t a i n i n g 125I-C ls, b o t h r e s i s t a n t strains, Willis a n d Davis, as well as one sensitive strain, F62, activated ~20% of the Cls, whereas the other sensitive strain, N24, activated a little more than 30% of the Cls (Table III, Fig. 2 ).
Activation and Binding of C5.
When NHS containing 125I-C5 was incubated with resistant and sensitive strains, both strains activated C5 as shown by the presence of C5a' in the pellets (Fig. 3) . Bacteria incubated with ANHS did not activate C5. In addition to activating C5, both resistant and sensitive strains bound comparable amounts of 125I-C5 to their surfaces at the end of 1 h incubation in NHS (Table IV) . Far less C5 bound to the bacteria in ANHS than in NHS. Specific binding was 8.0% for Willis and 8.8% for N24 after incubation with 0.05 ml NHS. When a larger volume of NHS (0.2 ml) containing leaI-C5 was incubated with the bacteria, more molecules of C5 were bound to the bacteria, but once again the amounts bound were Fro. 4. Sucrose density gradient ultracentrifugation analysis of SC5b-9 formation in NHS containing 125I-C5 incubated with serum-resistant and -sensitive N, gonorrhoeae. The sedimentation of 12SI-C5 (C5) and lzSI-SC5b-9 (SC5b-9) in the sucrose density gradient is indicated by arrows. Incorporation of azsI-C5 in SC5b-9 is shown for ANHS incubated with zymosan, and NHS incubated with zymosan, serum-resistant strain Willis, or sensitive strain N24.
similar for both resistant and sensitive strains. Nonspecific binding in this larger amount of ANHS was equal for both strains (1.3%) as was specific binding (6.2%).
125I-C5 and 131t-C9 Binding to Resistant and Sensitive N. gonorrhoeae. The simultaneous
binding of lz5I-C5 and talI-C9 was measured to assess formation of the MAC on the bacterial surfaces. Both the resistant strain Willis and the sensitive strain N24 specifically bound radiolabeled C5 and C9 (Table V) . In these experiments, l0 s bacteria were incubated with increasing amounts of NHS to which radiolabeled C5 and C9 had been added. The number of C5 and C9 molecules bound to both resistant and sensitive strains increased as the bacteria were incubated with increasing amounts of NHS. The binding of C9 to the bacteria was greater than that of C5 at higher serum concentration, resulting in a C9/C5 ratio with a maximum of 8.2 for Willis and 6.8 for N24. The nonspecific binding of 12SI-C5 and 131I-C9 to both strains in ANHS was very low compared with binding in NHS, and the ratio of C9/C5 bound to the bacteria in ANHS was much lower than in NHS.
12~I-C5 and la1I-C9 Binding to Resistant and Sensitive AT. gonorrhoeae. The simultaneous
binding of lz5I-C5 and t3II-C9 was measured to assess formation of the MAC on the bacterial surfaces. Both the resistant strain Willis and the sensitive strain N24 specifically bound radiolabeled C5 and C9 (Table V) . In these experiments, l0 s bacteria were incubated with increasing amounts of NHS to which radiolabeled C5 and C9 had been added. The number of C5 and C9 molecules bound to both resistant and sensitive strains increased as the bacteria were incubated with increasing amounts of NHS. The binding of C9 to the bacteria was greater than that of C5 at higher serum concentration, resulting in a C9/C5 ratio with a maximum of 8. 
SC5b-9 Formation by Resistant and Sensitive N. gonorrhoeae. N H S containing lz5I-C5
was incubated with bacteria, and then the radioactivity in the supernatant was ana[yzed by sucrose density gradient ultracentrifugation. Small amounts of 125I-C5 in N H S incubated with either resistant or sensitive bacteria sedimented in a position identical to that of SC5b-9 formed upon treatment of N H S with zymosan (Fig. 4) . The a m o u n t of 125I-C5 at this position in N H S incubated with the resistant strain Willis varied from 10.9% to 16.7% of the total azSI-C5 in the supernatant, whereas the sensitive strain N24 had 11.5%-11.9% 125I-C5 at this position.
Electron Microscopy of Resistant and Sensitive N. gonorrhoeae. After incubation with NHS, both resistant and sensitive strains of N. gonorrhoeae had typical c o m p l e m e n t lesions on their surfaces (Figs. 5 and 6 ). In a d d i t i o n to c o m p l e m e n t lesions, ring-like structures (inner diameter, 8 nm) can be seen on the surface of the bacteria incubated in N H S or ANHS (Fig. 5 B) . In contrast to the M A C , these c o m p l e m e n t -i n d e p e n d e n t ring structures do not extend above the surface of the bacterial m e m b r a n e as do the M A C (Fig. 6 B) . Serum-resistant strains exhibited the same 8-rim ring structures on their surface (not shown). After incubation with N H S , the serum-resistant strain Willis and -sensitive strain N24 both had numerous M A C deposited on their surface (Fig. 5 C -F ) , which were clearly distinguishable from the 8-nm ring structures. Another prominent feature was the blebbing of the outer m e m b r a n e of both resistant and sensitive bacteria. In some cases, fused m e m b r a n e blebs, with M A C on their surface, could be seen (Fig. 5 D) . This blebbing p h e n o m e n o n a p p e a r e d somewhat more prominent in the resistant strain.
Discussion
Our new finding regarding the interaction of human complement with N. gonorrhoeae is that the classical pathway of complement is specifically activated by resistant as well as sensitive N. gonorrhoeae. Complement activation by both types of bacteria is qualitatively and quantitatively similar and leads to MAC formation and stable deposition on the surface of both resistant and sensitive N. gonorrhoeae.
More specifically, we found that essentially 100% of the organisms of a serumsensitive strain, N24, were killed in NHS at concentrations that did not completely deplete the complement in NHS. With higher concentrations of organisms, the log10 killed diminished significantly. This probably occurred because the bactericidal capacity of NHS was approached at the highest concentration of bacteria, as evidenced by loss of measurable CHs0 activity in NHS incubated with 109 bacteria/ml. There was a clear dose-response relationship between the initial number of bacteria incubated with NHS and the number of sensitive bacteria killed, as well as the amount of CHs0 activity depleted by both resistant and sensitive bacteria.
Although resistant strains at various concentrations consumed comparable CHs0 to that of sensitive strains, they were not killed. At low concentrations (104/ml), a few of the resistant bacteria (20%-30%) seemed to be killed; however, because of errors inherent in the bactericidal assay and certain characteristics of the gonococcus (e.g., clumping), it is difficult to assess small amounts of killing. For these reasons, a significant amount of killing is usually defined as >1 log (29) . If, in fact, a small percent of resistant bacteria are killed by NHS, the cause is not a sensitive subpopulation, as shown by our cloning experiments. In addition, the killing of such a small percentage of bacteria would be unlikely to account for comparable amounts of CHs0 depletion by resistant and sensitive N. gonorrhoeae.
Stable serum resistance in N. gonorrhoeae does not result from lack of complement activation. Resistant as well as sensitive strains activate C ls and consume C2. Thus, both strains can activate the classical pathway. Because C2 represents the limiting component of the classical pathway, the decreased CH~0 probably represents C2 depletion, whereas the absence of detectable C4 or C7 depletion indicates the relative excess of these components in serum. The large number of bacteria required to detect C ls activation is also consistent with the presence of an excess of C 1 relative to C2 in serum.
The activation of C5 in NHS by both resistant and sensitive bacteria demonstrates that a C5 convertase had formed. After activation, C5b is bound to both resistant and sensitive strains as shown by equal deposition of C5b at the end of a 1-h incubation. As the amount of serum added was increased, additional molecules of C5b bound. C9 was also shown to remain bound to both resistant and sensitive bacteria. Previous reports have suggested that the ratio of C9 molecules to C5 molecules incorporated into the MAC, as measured by radiolabeled components, is -->6:1. The ratio of C9/C5 bound to both resistant and sensitive strains in these experiments suggests that these components were incorporated into the MAC. Although some SC5b-9 was formed by both resistant and sensitive bacteria, there was no marked difference in the amount formed by either strain.
Both resistant and sensitive strains had MAC deposited on their surfaces as seen in the electron microscope. Also apparent were inherent ring-like structures clearly distinguishable from MAC. These ring-like structures have been reported previously for the gonococcus (30) and meningococcus (31) . Another notable feature was blebbing of the membrane with release of vesicles from bacterial membranes. Although blebbing appeared somewhat more prominent in the resistant bacteria than in the sensitive strain, the significance is uncertain. Blebbing of membranes has also been reported previously for the gonococcus (32) .
Previous studies of serum-resistant and sensitive S. minnesota showed that both the resistant and sensitive strain activated complement (15, 16) . After complement activation, C5b-7 bound stably to the resistant Salmonella strain, but upon the addition of C8 and C9, the C5b-7 disassociated from the bacteria in the form of SC5b-9. This dissociation did not occur in the sensitive strain, rather the terminal components remained bound to the bacteria, presumably in the form of the MAC, and were capable of killing the bacteria.
The interactions of complement with resistant strains of S. minnesota and N. gonorrhoeae differ in several respects, suggesting different mechanisms of resistance. Although both activate the complement system, resistant S. minnesota consumes more terminal complement components than the sensitive strain (15, 16) , whereas resistant N. gonorrhoeae does not. Unlike resistant S. minnesota, the resistant N. gonorrhoeae have C5 and C9 bound to their surfaces at the end of 1 h of incubation, and the amounts of bound C5 and C9 are approximately equal to that of the sensitive strain. The ratios of C9/C5 bound to resistant and sensitive N. gonorrhoeae are comparable, 'and suggest that C5 and C9 are incorporated into MAC, unlike the decreased C9/C5 ratios observed on resistant S. minnesota (15, 16) . The amounts of SC5b-9 formed by both resistant and sensitive N. gonorrhoeae are also comparable, indicating no difference in release of terminal component complexes from bacterial surfaces. Finally, electron microscopy revealed MAC bound to both resistant and sensitive N. gonorrhoeae. Therefore, MAC is formed and remains on the surfaces of both resistant and sensitive N. gonorrhoeae after activation of complement.
Although MAC is formed and remains on the surface of resistant N. gonorrhoeae, the precise location of the MAC in the membrane is unknown. Our electron microscopy studies suggest that MAC becomes inserted in the outer membranes of some resistant bacteria, but the possible relationship between MAC location and viability remains to be determined. Possibly, a critical region on the bacterial surface determines killing.
Complement-mediated killing of Escherichia coli has been shown to occur with simultaneous release of markers from periplasmic and intracellular spaces (33, 34) . Some studies suggest the existence of regions in E. coli where inner and outer membranes join to form adhesion zones (35) . It is possible that MAC must insert at these critical regions of the bacterial surface to effect killing. Blocking antibodies are known to play a role in AT. gonorrhoeae serum resistance, and blocking antibody may prevent the insertion of MAC at these critical regions.
The precise events at a molecular level that determine serum-resistance in certain N. gonorrhoeae remain to be determined. Regardless of what the mechanism of resistance is, it will have to take account of the fact that serum-resistant iV. gonorrhoeae activate complement and bind MAC.
Summary
Interaction of the human complement system in normal human serum (NHS) with serum-resistant and -sensitive Neisseria gonorrhoeae was evaluated to better understand the mechanism of serum-resistance. Complement activity (CHs0) was depleted from NHS in a dose-dependent fashion by both serum-resistant and -sensitive N. gonorrhoeae.
No detectable CHs0 remained in NHS incubated with 109 colony-forming units (CFU)/ml serum of either resistant or sensitive strains. When smaller numbers of bacteria were incubated with NHS, lesser, yet comparable, amounts of CHs0 were depleted by both resistant and sensitive strains. Hemolytic C2 activity was diminished by 33% in the case of resistant N. gonorrhoeae (10 s CFU/ml serum) and by 48% in the case of a sensitive strain. No detectable decreases in hemolytic C4 or C7 activities were found with either sensitive or resistant strains at this concentration. Both resistant and sensitive strains activated C ls in NHS. Resistant strains specifically activated 19-21% ofradiolabeled C ls in NHS, whereas sensitive strains activated 18-32%. Both resistant and sensitive strains also activated C5 in NHS.
In binding assays using radiolabeled C5 and C9 in NHS, resistant and sensitive strains bound comparable amounts of C5 and C9. The number of bound C5 and C9 molecules varied according to the number of bacteria or amount of serum used in the assay. The ratio of C9/C5 bound to a sensitive strain was 6.8, and to a resistant strain was 8.2, suggesting that C5 and C9 were incorporated into membrane attack complexes (MAC). Electron microscopic examination of resistant and sensitive strains incubated with NHS revealed that MAC is bound to the surfaces of the resistant strain as well as the sensitive strain.
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